The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation

NCT02831894 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Hypnotic Dependence Among Those With Insomnia

Interventions

DRUG: 0% Hypnotic Medication Taper
DRUG: 25% Hypnotic Medication Taper
DRUG: 10% Hypnotic Medication Taper

Sponsor

National Jewish Health